Kearny-based Sigmund NJ, marketed as Trybe Labs, has been acquired by Hims & Hers — which is now expanding its offerings to include at-home blood tests.
The health and wellness company based out of San Francisco said it will be using blood lancets for testing so its consumers can get lab work done on a variety of health concerns including hormone levels, cardiac risk, stress markers, cholesterol, liver function, thyroid function and prostate health.
Health care providers on the Hims & Hers platform will then be able to use those tests results to help develop a personalized treatment plan for patients.
“Access to richer data allows us to deepen the insights that providers can use on our platform to guide their clinical decisions for each individual patient,” Hims & Hers Chief Medical Officer Dr. Patrick Carroll said in a press release. “At-home lab testing is one more exciting step towards elevating the personal, comprehensive care customers in this country should expect.”
Hims & Hers said the transaction is complete and was funded through cash, but it did not disclose how much it paid to acquire Sigmund NJ. The company plans to roll out its new blood tests to customers over the next year.
